Nisa Investment Advisors
AURA icon

Nisa Investment Advisors’s Aura Biosciences AURA Stock Holding History

Nisa Investment Advisors’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-36
Closed -$222 – 2976
2025
Q3 		$222 Hold
36
– – ﹤0.01% 2952
2025
Q2 		$225 Sell
36
-124
-78% -$725 ﹤0.01% 2987
2025
Q1 		$938 Sell
160
-31
-16% -$235 ﹤0.01% 2650
2024
Q4 		$1.57K Buy
191
+53
+38% +$499 ﹤0.01% 2566
2024
Q3 		$1.23K Hold
138
– – ﹤0.01% 2527
2024
Q2 		$1.04K Buy
138
+112
+431% +$820 ﹤0.01% 2508
2024
Q1 		$204 Buy
26
+16
+160% +$133 ﹤0.01% 2640
2023
Q4 		$89 Sell
10
-1,000
-99% -$8.47K ﹤0.01% 2618
2023
Q3 		$9.06K Buy
+1,010
New +$10.9K ﹤0.01% 2191

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Nisa Investment Advisors's AURA Position: Q4 2025 in Review

Nisa Investment Advisors sold out of Aura Biosciences (AURA) in Q4 2025, closing a stake of 36 shares — an estimated $222 sold.

Nisa Investment Advisors first reported a position in AURA in Q3 2023 and held it in 9 quarters. The position peaked at $9.06K in Q3 2023. 117 funds tracked by Wall St. Rank hold AURA as of Q4 2025.

  • Nisa Investment Advisors reported no remaining Aura Biosciences position as of Q4 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 36 Aura Biosciences shares in Q4 2025, an estimated $222.
  • Nisa Investment Advisors first reported a position in Aura Biosciences in Q3 2023 and held it in 9 quarters.
  • Nisa Investment Advisors's Aura Biosciences position peaked at $9.06K in Q3 2023.
  • 117 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2025.

Based on Nisa Investment Advisors's 13F filing for Q4 2025, filed 15 Jan 2026.